317 related articles for article (PubMed ID: 19906264)
1. Biomarkers in Huntington's and Parkinson's Disease.
O'Keeffe GC; Michell AW; Barker RA
Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
Marek K; Jennings D; Tamagnan G; Seibyl J
Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
[TBL] [Abstract][Full Text] [Related]
3. Network biomarkers for the diagnosis and treatment of movement disorders.
Poston KL; Eidelberg D
Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
5. The search for biomarkers in Parkinson's disease: a critical review.
Antoniades CA; Barker RA
Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
7. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
Outeiro TF; Giorgini F
Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
[TBL] [Abstract][Full Text] [Related]
8. Clinical measures of progression in Parkinson's disease.
Poewe W
Mov Disord; 2009; 24 Suppl 2():S671-6. PubMed ID: 19877235
[TBL] [Abstract][Full Text] [Related]
9. Can we image premotor Parkinson disease?
Marek K; Jennings D
Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic approaches to Parkinson's disease including neural transplants.
Kuan WL; Barker RA
Neurorehabil Neural Repair; 2005 Sep; 19(3):155-81. PubMed ID: 16093408
[TBL] [Abstract][Full Text] [Related]
11. Proteomics of Caenorhabditis elegans over-expressing human alpha-synuclein analyzed by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry: identification of actin and several ribosomal proteins as negative markers at early Parkinson's disease stages.
Ichibangase T; Saimaru H; Takamura N; Kuwahara T; Koyama A; Iwatsubo T; Imai K
Biomed Chromatogr; 2008 Mar; 22(3):232-4. PubMed ID: 17939164
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for the diagnosis and management of Parkinson's disease.
Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M
Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in Parkinson's disease.
Dorsey ER; Holloway RG; Ravina BM
Expert Rev Neurother; 2006 Jun; 6(6):823-31. PubMed ID: 16784406
[TBL] [Abstract][Full Text] [Related]
15. Free radicals in Parkinson's disease.
Koutsilieri E; Scheller C; Grünblatt E; Nara K; Li J; Riederer P
J Neurol; 2002 Sep; 249 Suppl 2():II1-5. PubMed ID: 12375056
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
Berg D
Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
[TBL] [Abstract][Full Text] [Related]
17. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
Singh MP; Patel S; Dikshit M; Gupta YK
Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for Parkinson's disease.
Graeber MB
Exp Neurol; 2009 Apr; 216(2):249-53. PubMed ID: 19166835
[TBL] [Abstract][Full Text] [Related]
19. Olfactory dysfunction in Parkinson's disease.
Wszolek ZK; Markopoulou K
Clin Neurosci; 1998; 5(2):94-101. PubMed ID: 10785834
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease.
Bohanna I; Georgiou-Karistianis N; Hannan AJ; Egan GF
Brain Res Rev; 2008 Jun; 58(1):209-25. PubMed ID: 18486229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
